Methods A non-concurrent prospective cohort study with 25 patients diagnosed with CRS having failed surgical and/or medical therapy on omalizumab and five control patients who met omalizumab therapy ...indications but could not access coverage.
Methods A log method was used to collect information on attack intensity, anatomical location, number of doses, onset of relief, time until complete resolution.
Rationale Cystic fibrosis (CF) is a genetic respiratory disease associated with airway obstruction and chronic lung infections. 7-9% of CF cases are complicated by allergic bronchopulmonary ...aspergillosis (ABPA).
Data extraction was performed and targeted demographic details, asthma, environmental allergy and CRS specific disease related data including self-reported major symptom improvement.
Methods After receiving a diagnosis of CSU with inadequate response to H1-antihistamines, and oral prednisone, patients completed a quality of life (QoL) questionnaire prior to beginning treatment ...with Omalizumab and every two weeks throughout the treatment.
Severe persistent allergic asthma can lead to the possibility of prolonged use of high doses of inhaled and oral corticosteroids, frequent emergency room (ER) visits with possible hospitalizations ...and frequent absences from work /school and social activities.
Conclusions Early treatment of moderate to severe asthma with omalizumab in adolescent/pediatric patients may improve quality of life and help prevent health concerns associated with side effects ...and/or long term use of ICS and OCS in growing children.
PDF
